- Home
- DERM vs WHG Comparison
DERM vs WHG Comparison
Compare DERM & WHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- WHG
- Stock Information
- Founded
- DERM 2014
- WHG 1983
- Country
- DERM United States
- WHG United States
- Employees
- DERM N/A
- WHG N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- WHG Investment Managers
- Sector
- DERM Health Care
- WHG Finance
- Exchange
- DERM Nasdaq
- WHG Nasdaq
- Market Cap
- DERM 181.0M
- WHG 146.3M
- IPO Year
- DERM 2021
- WHG 2002
- Fundamental
- Price
- DERM $8.06
- WHG $14.79
- Analyst Decision
- DERM Strong Buy
- WHG
- Analyst Count
- DERM 2
- WHG 0
- Target Price
- DERM $10.00
- WHG N/A
- AVG Volume (30 Days)
- DERM 103.3K
- WHG 17.3K
- Earning Date
- DERM 05-14-2025
- WHG 04-30-2025
- Dividend Yield
- DERM N/A
- WHG 4.06%
- EPS Growth
- DERM N/A
- WHG N/A
- EPS
- DERM N/A
- WHG 0.04
- Revenue
- DERM $56,243,000.00
- WHG $95,241,000.00
- Revenue This Year
- DERM $29.83
- WHG N/A
- Revenue Next Year
- DERM $54.88
- WHG N/A
- P/E Ratio
- DERM N/A
- WHG $309.53
- Revenue Growth
- DERM N/A
- WHG 6.08
- 52 Week Low
- DERM $3.54
- WHG $11.11
- 52 Week High
- DERM $8.24
- WHG $18.03
- Technical
- Relative Strength Index (RSI)
- DERM 65.90
- WHG 41.56
- Support Level
- DERM $6.55
- WHG $14.78
- Resistance Level
- DERM $7.00
- WHG $15.33
- Average True Range (ATR)
- DERM 0.63
- WHG 0.45
- MACD
- DERM 0.13
- WHG -0.01
- Stochastic Oscillator
- DERM 92.41
- WHG 26.42
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About WHG Westwood Holdings Group Inc
Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.